Lv6
2074 积分 2024-04-03 加入
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesis
7天前
已完结
Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results
9天前
已完结
Late Breaking Abstract - Efficacy of a monoclonal antibody against IL-25 in human allergic asthma: an open-label, single-arm, phase Ic study
11天前
已关闭
First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers
11天前
已完结
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
11天前
已完结
De novo discovery of cyclic peptide inhibitors of IL-11 signaling
15天前
已完结
Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer
24天前
已完结
S100A4: A calcium-binding protein at the crossroads of cancer, fibrosis, and antiviral immunity
1个月前
已完结
EXTH-122. A novel S100A4/TFR bispecific antibody to reprogram the GBM tumor microenvironment and reactivate anti-tumor immunity
1个月前
已完结
S100A4 a classical DAMP as a therapeutic target in fibrosis
1个月前
已完结
皖公网安备34019202002308
